Basic Information
ID: ALA1926126
Type: Functional
Description: Growth inhibition of doxorubicin-susceptible human CH1 cells after 96 hrs by sulforhodamine B assay
Organism: Homo sapiens
Cell type: CH1
Activity Charts
Bioactivity
Activity Types for Assay ALA1926126
GI50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 354.46 | 3.20 | 3.20 |
| 355.45 | 2.60 | 2.60 |
| 355.45 | 2.60 | 2.60 |
| 355.45 | 2.60 | 2.60 |
| 369.47 | 2.99 | 2.99 |
| 383.50 | 3.38 | 3.38 |
| 397.53 | 3.62 | 3.62 |
| 411.55 | 4.01 | 4.01 |
| 383.50 | 3.38 | 3.38 |
| 369.47 | 2.99 | 2.99 |
| 383.50 | 3.38 | 3.38 |
| 397.53 | 3.62 | 3.62 |
| 411.55 | 4.01 | 4.01 |
| 383.50 | 3.38 | 3.38 |
| 368.49 | 3.59 | 3.59 |
| 382.51 | 3.98 | 3.98 |
| 396.54 | 4.23 | 4.23 |
| 410.57 | 4.62 | 4.62 |
| 382.51 | 3.98 | 3.98 |
| 369.47 | 2.99 | 2.99 |
| 383.50 | 3.38 | 3.38 |
| 397.53 | 3.62 | 3.62 |
| 411.55 | 4.01 | 4.01 |
| 383.50 | 3.38 | 3.38 |
| 369.47 | 2.99 | 2.99 |
| 383.50 | 3.38 | 3.38 |
| 397.53 | 3.62 | 3.62 |
| 411.55 | 4.01 | 4.01 |
| 383.50 | 3.38 | 3.38 |
| 368.49 | 3.59 | 3.59 |
| 382.51 | 3.98 | 3.98 |
| 396.54 | 4.23 | 4.23 |
| 410.57 | 4.62 | 4.62 |
| 382.51 | 3.98 | 3.98 |